Biagio D.
- Country
- Italy
- Department
- I Divisione Dermatologia
Research Overview
- Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adults with Bullous Pemphigoid: An Open-label Extension Study
- Efficacy and Safety Evaluation of Diacerein 1% Ointment in Generalized Epidermolysis Bullosa Simplex: A Randomized, Double-Blind, Vehicle-Controlled Study
- Efficacy and Safety Evaluation of Efgartigimod PH20 SC in Adults with Bullous Pemphigoid: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 33 of 73 partner sites.
Specializations
Autoimmune Skin Disorders
The investigator specializes in treating bullous pemphigoid, focusing on innovative therapeutic approaches using novel biological agents. Their research encompasses long-term management strategies and sustained remission protocols for this chronic autoimmune blistering condition.
- Bullous Pemphigoid Management
- Autoimmune Blistering Diseases
- Biological Therapy Applications
Rare Genetic Skin Conditions
The investigator conducts research in rare genetic skin disorders, particularly Netherton syndrome and various forms of epidermolysis bullosa, including generalized epidermolysis bullosa simplex (EBS). Their work involves evaluating novel therapeutic approaches for these challenging conditions.
- Epidermolysis Bullosa Treatment
- Genetic Skin Disorders
- Wound Healing Therapeutics
Therapeutic Development
The investigator's expertise extends to evaluating both topical and systemic treatments for severe skin conditions. Their research encompasses novel drug delivery systems and assessment of therapeutic responses in challenging dermatological conditions.
- Topical Treatment Development
- Clinical Efficacy Assessment
- Long-term Safety Monitoring
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.